Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study

Inflammatory Bowel Diseases · Published 2026-07-22 · DOI 10.1093/ibd/izag126

Authors (25)

Nalan Gülşen Ünal, Oğuz Kağan Bakkaloğlu, Taylan Kav, Tuğçe Eşkazan, Haluk Tarık Kani, Atilla Akpınar, Pırıl Akıncıoğlu, Gizem Dağcı, İbrahim Şendur, İlker Büyüktorun, Sezgin Barutçu, Güner Kılıç, Göksel Bengi, Bilger Çavuş, Nevin Oruç, Yeşim Özen Alahdab, Özlen Atuğ, Dinç Dinçer, Tarkan Karakan, Ali İbrahim Hatemi, Yusuf Ziya Erzin, Ahmet Tezel, Murat Törüner, Filiz Akyüz, Aykut Ferhat Çelik

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ünal, N., Bakkaloğlu, O., Kav, T., et al. (2026). Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag126

Related articles